European Society of Cutaneous Lupus Erythematosus (EUSCLE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00420121|
Recruitment Status : Enrolling by invitation
First Posted : January 9, 2007
Last Update Posted : February 8, 2017
|Condition or disease||Intervention/treatment|
|Lupus Erythematosus, Cutaneous Lupus Erythematosus, Systemic||Procedure: laboratory analysis|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||European Society of Cutaneous Lupus Erythematosus|
|Study Start Date :||January 2007|
|Estimated Primary Completion Date :||July 2018|
|Estimated Study Completion Date :||December 2019|
- Procedure: laboratory analysis
blood withdrawal for laboratory analysis
- Activity and Damage of Skin Lesions in Patients with Cutaneous Lupus Erythematosus measured by the RCLASI Activity and Damage Score. [ Time Frame: Up to 12 months ]
The Total RCLASI Activity Score measures (i) the activity of skin lesions by evaluating the parameters "erythema", "scaling ⁄hyperkeratosis", "oedema ⁄Infiltration", and "subcutaneous nodule ⁄plaque" and/or (ii) the activity of mucous membrane lesions and/or (iii) the activity of alopecia.
The Total RCLASI Damage Score measures (i) the damage of skin lesions by evaluating the parameters "dyspigmentation" and "scarring/atrophy" and/or (ii) the damage of scarring alopecia.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00420121
|University of Muenster, Department of Dermatology|
|Muenster, NRW, Germany, 48149|
|Principal Investigator:||Annegret Kuhn, MD||University of Muenster, Department of Dermatology|